Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Centene (CNC) Stock Price & Analysis

3,076 Followers

CNC Stock Chart & Stats

$70.48$0.29(0.41%)
At close: 4:00 PM EST
$60$65$70$75Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$69.97 - $71.08
52-Week Range
$31.63 - $78.08
Previous Close
$70.19
Volume
N/A
Average Volume (3M)
5.30M
Market Cap
$34.75B
Enterprise Value
$46.34B
Total Cash (Recent Filing)
$23.59B
Total Debt (Recent Filing)
$15.54B
Price to Earnings (P/E)
23.8
Beta
0.39
Next Earnings
Feb 09, 2027 (Est.)
EPS Estimate
-1.15
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

Rapid revenue expansion demonstrates strong demand across Centene’s government-sponsored and Marketplace businesses. Continued top-line growth can broaden operating scale, support investment in care-management capabilities, and provide a durable base for improving earnings if medical costs remain controlled.

Medicare Advantage Turnaround

Reaching Medicare Advantage breakeven earlier than planned signals meaningful improvement in pricing, utilization management, and execution. The expected move to better-than-breakeven results in 2027 could make the segment a more reliable contributor while Centene focuses growth on differentiated markets.

Debt Reduction

Substantial debt reduction improves financial flexibility and lowers interest expense, while eliminating near-term maturities reduces refinancing pressure. A stronger balance sheet gives Centene more capacity to fund growth, absorb medical-cost volatility, and pursue operational investments.

Bears Say

Volatile, Thin Profitability

Profitability has not yet demonstrated consistent durability despite strong revenue growth. The 2025 loss and low TTM operating margin indicate that medical utilization, execution, or other cost pressures can quickly erode earnings and limit the conversion of scale into shareholder returns.

Medicaid Membership Decline

Sustained Medicaid membership attrition can reduce premium revenue and operating scale in Centene’s largest business. Eligibility terminations and work requirements may also change member acuity, creating rate-alignment risk and making medical-cost performance harder to manage across future cycles.

PDP Margin Reset

The expected Part D margin reset shows that current segment profitability is not fully sustainable. Lower PDP margins could offset gains from enrollment growth and require continued cost-structure discipline, leaving consolidated earnings more dependent on performance in Medicaid, Marketplace, and Medicare Advantage.

Centene News

CNC FAQ

What was Centene’s price range in the past 12 months?
Centene lowest stock price was $31.63 and its highest was $78.08 in the past 12 months.
What is Centene’s market cap?
Centene’s market cap is $34.75B.
When is Centene’s upcoming earnings report date?
Centene’s next earnings report is estimated for Feb 09, 2027 (not yet confirmed), which is in 89 days.
How were Centene’s earnings last quarter?
Centene released its earnings results on Oct 27, 2026. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.096 by $0.484.
Is Centene overvalued?
According to Wall Street analysts Centene’s price is currently Undervalued.
Does Centene pay dividends?
Centene does not currently pay dividends.
What is Centene’s EPS estimate?
Centene’s EPS estimate is -1.15.
How many shares outstanding does Centene have?
Centene has 495,068,000 shares outstanding.
What happened to Centene’s price movement after its last earnings report?
Centene reported an EPS of $0.58 in its last earnings report, beating expectations of $0.096. Following the earnings report the stock price went up 1%.
Which hedge fund is a major shareholder of Centene?
Hedge funds hold Centene shares: the largest hedge-fund position in Centene is 71,884,386 shares, and hedge funds decreased their holdings by 1.5M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology